Form 4: Director Pamela Kimmet Receives Privia Health Equity Grant

Director Pamela Kimmet was granted 8,463 restricted stock units in Privia Health Group, Inc. as part of the company's 2021 Omnibus Incentive Plan.

Summary

• Director Pamela Kimmet acquired 8,463 restricted stock units (RSUs) on May 20, 2026.
• The grant was issued under the Privia Health Group, Inc. 2021 Omnibus Incentive Plan.
• Following this transaction, the reporting person's total beneficial ownership increased to 34,172 shares of common stock.
• The RSUs are scheduled to vest on the earlier of the day before the 2027 annual meeting or the first anniversary of the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Standard market risks associated with equity ownership and potential volatility in the company's share price.

Future Outlook

The RSUs are expected to vest by May 2027 or the date of the 2027 annual meeting of stockholders, whichever occurs first.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice designed to incentivize long-term oversight and alignment with shareholder interests in the healthcare services sector.

Comparison to Industry Standards

• The use of restricted stock units for director compensation is consistent with standard practices for mid-cap healthcare companies.
• Vesting schedules tied to annual meetings are common industry practice for board members.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity incentive grant.

Next Steps

• Vesting of the 8,463 restricted stock units in 2027.

Key Dates

Keywords

Privia Health Group, PRVA, Form 4, Insider Transaction, Equity Compensation, Director Stock Grant